Cite

1. S. S. Liou, W. L. Sheih, T. H. Cheng, S. J. Won and C. N. Lin, γ-Pyrone compounds as potential anticancer drugs, J. Pharm. Parmacol.45 (1993) 791–794; https://doi.org/10.1111/j.2042-7158.1993.tb05686.x10.1111/j.2042-7158.1993.tb05686.x7903365Search in Google Scholar

2. K. Muharrem, D. Ersin and B. Hatice, Synthesis, characterization and antimicrobial activity of novel xanthene sulfonamide and carboxamide derivatives, J. Enzyme Inhib. Med. Chem.28 (2013) 885–893; https://doi.org/10.3109/14756366.2012.69208710.3109/14756366.2012.69208722803669Search in Google Scholar

3. B. C. Baguley and L. M. Ching, Immunomodulatory actions of xanthenone anticancer agents, BioDrugs8 (1997) 119–127; https://doi.org/10.2165/00063030-199708020-0000510.2165/00063030-199708020-0000518020500Search in Google Scholar

4. A. E. Hay, M. C. Aumond, S. Mallet, V. Dumontet, M. Litaudon, D. Rondeau and P. Richomme, Antioxidant xanthones from Garcinia vieillardii, J. Nat. Prod.67 (2004) 707–709; https://doi.org/10.1021/np030497110.1021/np030497115104511Search in Google Scholar

5. Z. Karimi-Jaberi and M. M. Hashemi, One step synthesis of 14-alkyl-or aryl-14H-dibenzo [a,j] xanthenes using sodium hydrogen sulfate as catalyst, Monatsh. Chem.139 (2008) 605–608; https://doi.org/10.1007/s00706-007-0786-z10.1007/s00706-007-0786-zSearch in Google Scholar

6. S. Laphookhieo, J. K. Syers, R. Kiattansakul and K. Chantrapromma, Cytotoxic and antimalarial prenylated xanthones from Cratoxylum cochinchinense, Chem. Pharm. Bull.54 (2006) 745–747; https://doi.org/10.1248/cpb.54.74510.1248/cpb.54.74516651783Search in Google Scholar

7. Q. B. Han, N. Y. Yang, H. L. Tian, C. F. Qiao, J. Z. Song, D. C. Chang, S. L. Chen, K. Q. Luo and H. X. Xu, Xanthones with growth inhibition against HeLa cells from Garcinia xipshuanbannaensis, Phytochemistry69 (2008) 2187–2192; https://doi.org/10.1016/j.phytochem.2008.05.01910.1016/j.phytochem.2008.05.01918614188Search in Google Scholar

8. S. L. Niu, Z. L. Li, F. Ji, G. Y. Liu, N. Zhao, X. Q. Liu, Y. K. Jing and H. M. Hua, Xanthones from the stem bark of Garcinia bracteata with growth inhibitory effects against HL-60 cells, Phytochemistry77 (2012) 280–286; https://doi.org/10.1016/j.phytochem.2012.01.01010.1016/j.phytochem.2012.01.01022325589Search in Google Scholar

9. A. Nersesyan, E. Perrone, P. Roggieri and C. Bolognesi, Genotoxic action of cycloplatam, a new platinum antitumor drug, on mammalian cells in vivo and in vitro, Chemotherapy49 (2003) 132–137; https://doi.org/10.1159/00007061910.1159/00007061912815206Search in Google Scholar

10. G. P. Machado, J. I. González Borroto, N. Castañedo, A. Creus and R. Marcos, In vitro genotoxicity testing of the furylethylene derivative UC-245 in human cells, Mutagenesis 19 (2004) 75–80; https://doi.org/10.1093/mutage/geg03910.1093/mutage/geg03914681316Search in Google Scholar

11. A. K. Nersesyan, G. S. Melikyan and H. Stopper, The study of genotoxicity of two newly synthesized pyrrolinone derivatives on L5178Y mouse lymphoma and bone marrow cells, Exp. Oncol.25 (2003) 176–179.Search in Google Scholar

12. F. Karaer, Environmental pollution and carcinogenic risk, J. Environ. Pathol., Toxicol. Oncol.15 (1996) 105–113.Search in Google Scholar

13. M. S. Legator and W. W. Au, Application of integrated genetic monitoring: the optimal approach for detecting environmental carcinogens, Environ. Health Perspect.102 (1994) 125–132; https://doi.org/10.1289/ehp.94102s912510.1289/ehp.94102s912515667787698074Search in Google Scholar

14. M. Fenech, Cytokinesis-block micronucleus cytome assay, Nat. Protoc.2 (2007) 1084; https://doi.org/10.1038/nprot.2007.7710.1038/nprot.2007.7717546000Search in Google Scholar

15. L. Applova, E. Veljović, S. Muratović, J. Karličkova, K. Macakova, D. Završnik, L. Saso, K. Durić and P. Mladenka, 9-(4’-Dimethylaminophenyl)-2,6,7-trihydroxy-xanthene-3-one is a Potentially Novel Antiplatelet Drug which Antagonizes the Effect of Thromboxane A2, Med. Chem.14 (2018) 1–10; https://doi.org/10.2174/157340641366617101010253510.2174/157340641366617101010253529032760Search in Google Scholar

16. E. Veljović, S. Špirtović-Halilović, S. Muratović, M. Salihović, I. Novaković, A. Osmanović and D. Završnik, Antimicrobial Activity and Docking Study of Synthesized Xanthen-3-one Derivatives, Res. J. Pharm. Biol. Chem. Sci.9 (2018) 777–783.Search in Google Scholar

17. H. Marona, N. Szkaradek, E. Karczewska, D. Trojanowska, A. Budak, P. Bober, W. Przepiorka, M. Cegla and E. Szneler, Antifungal and Antibacterial Activity of the Newly Synthesized 2-Xanthone Derivatives, Arch. Pharm.342 (2009) 9–18; https://doi.org/10.1002/ardp.20080008910.1002/ardp.20080008919051197Search in Google Scholar

18. S. Gobbi, A. Rampa, A. Bisi, F. Belluti, P. Valenti, A. Caputo, A. Zampiron and M. Carrara, Synthesis and antitumor activity of new derivatives of xanthen-9-one-4-acetic acid, J. Med. Chem.45 (2002) 4931–4939; https://doi.org/10.1021/jm020929p10.1021/jm020929p12383019Search in Google Scholar

19. X. Z. Wang, J. H. Yao, G. B. Jiang, J. Wang, H. L. Huang and Y. L. Liu, Synthesis, characterization, cytotoxicity, apoptosis and cell cycle arrest of dibenzoxanthenes derivatives, Spectrochim. Acta, Part A133 (2014) 559–567; https://doi.org/10.1016/j.saa.2014.05.05410.1016/j.saa.2014.05.05424992915Search in Google Scholar

20. E. Veljović, S. Špirtović-Halilović, S. Muratović, L. Valek Žulj, S. Roca, S. Trifunović, A. Osmanović and D. Završnik, 9-Aryl Substituted Hydroxylated Xanthen-3-ones: Synthesis, Structure and Antioxidant Potency Evaluation, Croat. Chem. Acta88 (2015) 121–127; https://doi.org/10.5562/cca259510.5562/cca2595Search in Google Scholar

21. S. Petra, G. Klaus and R. W. Siegfries, Reliable synthesis of 9-aryl-substituted 2,6,7-trihydroxyxanthen-3-ones, Synthesis14 (2008) 2211–2216; https://doi.org/10.1055/s-2008-107844710.1055/s-2008-1078447Search in Google Scholar

22. T. Gazivoda, S. Raić-Malić, S. Krištafor, D. Makuc, J. Plavec, S. Bratulić, S. Kraljević Pavelić, K. Pavelić, L. Naesens, G. Andrei, R. Snoeck, J. Balzarini and M. Mintas, Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues, Bioorg. Med. Chem.16 (2008) 5624–5634; https://doi.org/10.1016/j.bmc.2008.03.07410.1016/j.bmc.2008.03.074712749118424155Search in Google Scholar

23. G. M. Morris, R. Huey, W. Lindstrom, M. F. Sanner, R. K. Belew, D. S. Goodsell and A. J. Olson, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility J. Comput. Chem.30 (2009) 2785–2791; https://doi.org/10.1002/jcc.2125610.1002/jcc.21256276063819399780Search in Google Scholar

24. M. A. Lill and M. L. Danielson, Computer-aided drug design platform using PyMOL, J. Comput.-Aided Mol. Des.25 (2011) 13–19; https://doi.org/10.1007/s10822-010-9395-810.1007/s10822-010-9395-8Search in Google Scholar

25. M. Fenech, The in vitro micronucleus technique, Mutat. Res., Fundam. Mol. Mech. Mutagen.455 (2000) 81–95; https://doi.org/10.1016/S0027-5107(00)00065-810.1016/S0027-5107(00)00065-8Search in Google Scholar

26. M. Fenech, W. P. Chang, M. Kirsch-Volders, N. Holland, S. Bonassi and E. Zeiger, HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures, Mutat. Res., Genet. Toxicol. Environ. Mutagen.534 (2003) 65–75; https://doi.org/10.1016/S1383-5718(02)00249-810.1016/S1383-5718(02)00249-8Search in Google Scholar

27. O. Hammer, D. A. T. Harper and P. D. Ryan, PAST-Palaeontological statistics. www.uv.es/~pardomv/pe/2001_1/past/pastprog/past.pdf, acessado em, 25 (2001) 2009.Search in Google Scholar

28. J. Azizian, M. K. Mohammadi, O. Firuzi, N. Razzaghi-asl and R. Miri, Synthesis, biological activity and docking study of some new isatin Schiff base derivatives, Med. Chem. Res.21 (2012) 3730–3740; https://doi.org/10.1007/s00044-011-9896-610.1007/s00044-011-9896-6Search in Google Scholar

29. E. Gordian, E. Welsh and T. Muñoz-Antonia, Alvespimycin (17-DMAG) blocks TGFβ-induced EMT and migration in A549 lung cancer cells, Cancer Res.74 (2014) 1916–1930; https://doi.org/10.1158/1538-7445.AM2014-105010.1158/1538-7445.AM2014-1050Search in Google Scholar

30. P. Xia, F. F. Mou and L. W. Wang, Predictive Role of Computer Simulation in Assessing Signaling Pathways of Crizotinib-treated A549 Lung Cancer Cells, Asian Pac. J. Cancer Prev.13 (2012) 3119–3121; https://doi.org/10.7314/APJCP.2012.13.7.311910.7314/APJCP.2012.13.7.3119Search in Google Scholar

31. A. F. Eweas, Q. M. A. Abdullah and E. S. I. Hassan, Design, synthesis, molecular docking of new thiopyrimidine-5-carbonitrile derivatives and their cytotoxic activity against HepG2 cell line, J. Appl. Pharm. Sci.4 (2014) 102–111; https://doi.org/10.7324/JAPS.2014.4121810.7324/JAPS.2014.41218Search in Google Scholar

32. R. J. Coffey, G. D. Shipley and H. L. Moses, Production of transforming growth factors by human colon cancer lines, Cancer Res.46 (1986) 1164–1169.Search in Google Scholar

33. F. M. Drumond Chequer, V. P. Venâncio, M. L. Bianchi abd L. M. Antunes, Genotoxic and mutagenic effects of erythrosine B, a xanthene food dye, on HepG2 cells, Food. Chem. Toxicol.50 (2012) 3447–3451; https://doi.org/10.1016/j.fct.2012.07.04210.1016/j.fct.2012.07.04222847138Search in Google Scholar

34. A. Eisentraeger, C. Brinkmann, H. Hollert, A. Sagner, A. Tiehm and J. Neuwoehner, Heterocyclic compounds: toxic effects using algae, daphnids, and the Salmonella/microsome test taking methodical quantitative aspects into account, Environ. Toxicol. Chem.27 (2008) 1590–1596; https://doi.org/10.1897/07-201.110.1897/07-201.1Search in Google Scholar

eISSN:
1846-9558
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Pharmacy, other